1. Home
  2. Pharma & Healthcare
  3. Global mRNA Vaccines & Therapeutics Market Growth (Status and Outlook) 2020-2025

Global mRNA Vaccines & Therapeutics Market Growth (Status and Outlook) 2020-2025

Publication Month: Sep 2020 | No. of Pages: 119 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this study, over the next five years the mRNA Vaccines & Therapeutics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in mRNA Vaccines & Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the mRNA Vaccines & Therapeutics, covering the supply chain analysis, impact assessment to the mRNA Vaccines & Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by mRNA Vaccines & Therapeutics companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Infectious Disease Vaccines
Cancer Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Infectious Disease
Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Moderna Therapeutics
Tiba Biotechnology
CureVac
BioNTech
Sangamo Therapeutics
Translate Bio
eTheRNA
Argos Therapeutics
Ethris
In-Cell-Art

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global mRNA Vaccines & Therapeutics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of mRNA Vaccines & Therapeutics market by identifying its various subsegments.
Focuses on the key global mRNA Vaccines & Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the mRNA Vaccines & Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of mRNA Vaccines & Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Vaccines & Therapeutics Market Size 2015-2025
2.1.2 mRNA Vaccines & Therapeutics Market Size CAGR by Region
2.2 mRNA Vaccines & Therapeutics Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Infectious Disease Vaccines
2.3 mRNA Vaccines & Therapeutics Market Size by Type
2.3.1 Global mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
2.3.2 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (2015-2020)
2.4 mRNA Vaccines & Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Other
2.5 mRNA Vaccines & Therapeutics Market Size by Application
2.5.1 Global mRNA Vaccines & Therapeutics Market Size Market Share by Application (2015-2020)
2.5.2 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application (2015-2020)

3 Global mRNA Vaccines & Therapeutics by Players
3.1 Global mRNA Vaccines & Therapeutics Market Size Market Share by Players
3.1.1 Global mRNA Vaccines & Therapeutics Market Size by Players (2018-2020)
3.1.2 Global mRNA Vaccines & Therapeutics Market Size Market Share by Players (2018-2020)
3.2 Global mRNA Vaccines & Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 mRNA Vaccines & Therapeutics by Regions
4.1 mRNA Vaccines & Therapeutics Market Size by Regions
4.2 Americas mRNA Vaccines & Therapeutics Market Size Growth
4.3 APAC mRNA Vaccines & Therapeutics Market Size Growth
4.4 Europe mRNA Vaccines & Therapeutics Market Size Growth
4.5 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Growth

5 Americas
5.1 Americas mRNA Vaccines & Therapeutics Market Size by Countries
5.2 Americas mRNA Vaccines & Therapeutics Market Size by Type
5.3 Americas mRNA Vaccines & Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC mRNA Vaccines & Therapeutics Market Size by Regions
6.2 APAC mRNA Vaccines & Therapeutics Market Size by Type
6.3 APAC mRNA Vaccines & Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe mRNA Vaccines & Therapeutics by Countries
7.2 Europe mRNA Vaccines & Therapeutics Market Size by Type
7.3 Europe mRNA Vaccines & Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Countries
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Type
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global mRNA Vaccines & Therapeutics Market Forecast
10.1 Global mRNA Vaccines & Therapeutics Market Size Forecast (2021-2025)
10.2 Global mRNA Vaccines & Therapeutics Forecast by Regions
10.2.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global mRNA Vaccines & Therapeutics Forecast by Type
10.8 Global mRNA Vaccines & Therapeutics Forecast by Application

11 Key Players Analysis
11.1 Moderna Therapeutics
11.1.1 Company Details
11.1.2 mRNA Vaccines & Therapeutics Product Offered
11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Moderna Therapeutics News
11.2 Tiba Biotechnology
11.2.1 Company Details
11.2.2 mRNA Vaccines & Therapeutics Product Offered
11.2.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Tiba Biotechnology News
11.3 CureVac
11.3.1 Company Details
11.3.2 mRNA Vaccines & Therapeutics Product Offered
11.3.3 CureVac mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 CureVac News
11.4 BioNTech
11.4.1 Company Details
11.4.2 mRNA Vaccines & Therapeutics Product Offered
11.4.3 BioNTech mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 BioNTech News
11.5 Sangamo Therapeutics
11.5.1 Company Details
11.5.2 mRNA Vaccines & Therapeutics Product Offered
11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Sangamo Therapeutics News
11.6 Translate Bio
11.6.1 Company Details
11.6.2 mRNA Vaccines & Therapeutics Product Offered
11.6.3 Translate Bio mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Translate Bio News
11.7 eTheRNA
11.7.1 Company Details
11.7.2 mRNA Vaccines & Therapeutics Product Offered
11.7.3 eTheRNA mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 eTheRNA News
11.8 Argos Therapeutics
11.8.1 Company Details
11.8.2 mRNA Vaccines & Therapeutics Product Offered
11.8.3 Argos Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Argos Therapeutics News
11.9 Ethris
11.9.1 Company Details
11.9.2 mRNA Vaccines & Therapeutics Product Offered
11.9.3 Ethris mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Ethris News
11.10 In-Cell-Art
11.10.1 Company Details
11.10.2 mRNA Vaccines & Therapeutics Product Offered
11.10.3 In-Cell-Art mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 In-Cell-Art News

12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. mRNA Vaccines & Therapeutics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Infectious Disease Vaccines
Table 5. Major Players of Cancer Vaccines
Table 6. mRNA Vaccines & Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table 7. Global mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
Table 8. Global mRNA Vaccines & Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 9. Global mRNA Vaccines & Therapeutics Market Size Market Share by Application (2015-2020)
Table 10. Global mRNA Vaccines & Therapeutics Revenue by Players (2018-2020) ($ Millions)
Table 11. Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2018-2020)
Table 12. Global mRNA Vaccines & Therapeutics Key Players Head office and Products Offered
Table 13. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Vaccines & Therapeutics Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global mRNA Vaccines & Therapeutics Market Size Market Share by Regions 2015-2020
Table 18. Americas mRNA Vaccines & Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Countries (2015-2020)
Table 20. Americas mRNA Vaccines & Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
Table 22. Americas mRNA Vaccines & Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Application (2015-2020)
Table 24. APAC mRNA Vaccines & Therapeutics Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Regions (2015-2020)
Table 26. APAC mRNA Vaccines & Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
Table 28. APAC mRNA Vaccines & Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Application (2015-2020)
Table 30. Europe mRNA Vaccines & Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Countries (2015-2020)
Table 32. Europe mRNA Vaccines & Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
Table 34. Europe mRNA Vaccines & Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of mRNA Vaccines & Therapeutics
Table 43. Key Application and Potential Industries of mRNA Vaccines & Therapeutics
Table 44. Key Challenges of mRNA Vaccines & Therapeutics
Table 45. Key Trends of mRNA Vaccines & Therapeutics
Table 46. Global mRNA Vaccines & Therapeutics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global mRNA Vaccines & Therapeutics Market Size Market Share Forecast by Regions
Table 48. Global mRNA Vaccines & Therapeutics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global mRNA Vaccines & Therapeutics Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global mRNA Vaccines & Therapeutics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global mRNA Vaccines & Therapeutics Market Size Market Share Forecast by Application (2021-2025)
Table 52. Moderna Therapeutics Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 53. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 54. Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 55. Moderna Therapeutics Main Business
Table 56. Moderna Therapeutics Latest Developments
Table 57. Tiba Biotechnology Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 58. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
Table 59. Tiba Biotechnology Main Business
Table 60. Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 61. Tiba Biotechnology Latest Developments
Table 62. CureVac Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 63. CureVac mRNA Vaccines & Therapeutics Product Offered
Table 64. CureVac Main Business
Table 65. CureVac mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 66. CureVac Latest Developments
Table 67. BioNTech Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 68. BioNTech mRNA Vaccines & Therapeutics Product Offered
Table 69. BioNTech Main Business
Table 70. BioNTech mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 71. BioNTech Latest Developments
Table 72. Sangamo Therapeutics Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 73. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 74. Sangamo Therapeutics Main Business
Table 75. Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 76. Sangamo Therapeutics Latest Developments
Table 77. Translate Bio Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 78. Translate Bio mRNA Vaccines & Therapeutics Product Offered
Table 79. Translate Bio Main Business
Table 80. Translate Bio mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 81. Translate Bio Latest Developments
Table 82. eTheRNA Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 83. eTheRNA mRNA Vaccines & Therapeutics Product Offered
Table 84. eTheRNA Main Business
Table 85. eTheRNA mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 86. eTheRNA Latest Developments
Table 87. Argos Therapeutics Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 88. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 89. Argos Therapeutics Main Business
Table 90. Argos Therapeutics mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 91. Argos Therapeutics Latest Developments
Table 92. Ethris Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 93. Ethris mRNA Vaccines & Therapeutics Product Offered
Table 94. Ethris Main Business
Table 95. Ethris mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 96. Ethris Latest Developments
Table 97. In-Cell-Art Details, Company Total Revenue (in $ million), Head Office, mRNA Vaccines & Therapeutics Major Market Areas and Its Competitors
Table 98. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
Table 99. In-Cell-Art Main Business
Table 100. In-Cell-Art mRNA Vaccines & Therapeutics Revenue and Gross Margin (2018-2020E)
Table 101. In-Cell-Art Latest Developments
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global mRNA Vaccines & Therapeutics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global mRNA Vaccines & Therapeutics Market Size Market Share by Type (2015-2020)
Figure 5. Global Infectious Disease Vaccines Market Size Growth Rate
Figure 6. Global Cancer Vaccines Market Size Growth Rate
Figure 7. mRNA Vaccines & Therapeutics in Infectious Disease
Figure 8. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2015-2020) ($ Millions)
Figure 9. mRNA Vaccines & Therapeutics in Cancer
Figure 10. Global mRNA Vaccines & Therapeutics Market: Cancer (2015-2020) ($ Millions)
Figure 11. mRNA Vaccines & Therapeutics in Other
Figure 12. Global mRNA Vaccines & Therapeutics Market: Other (2015-2020) ($ Millions)
Figure 13. Global Other YoY Growth ($ Millions)
Figure 14. Global mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2019
Figure 15. Global mRNA Vaccines & Therapeutics Market Size Market Share by Regions 2015-2020
Figure 16. Americas mRNA Vaccines & Therapeutics Market Size 2015-2020 ($ Millions)
Figure 17. APAC mRNA Vaccines & Therapeutics Market Size 2015-2020 ($ Millions)
Figure 18. Europe mRNA Vaccines & Therapeutics Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2015-2020 ($ Millions)
Figure 20. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Countries in 2019
Figure 21. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2019
Figure 22. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2019
Figure 23. United States mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Regions in 2019
Figure 27. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2019
Figure 28. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2019
Figure 29. China mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 33. India mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Countries in 2019
Figure 36. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2019
Figure 37. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2019
Figure 38. Germany mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 39. France mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2019
Figure 46. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2019
Figure 47. Egypt mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries mRNA Vaccines & Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global mRNA Vaccines & Therapeutics arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 54. APAC mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 55. Europe mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 57. United States mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 58. Canada mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 59. Mexico mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 60. Brazil mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 61. China mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 62. Japan mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 63. Korea mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 65. India mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 66. Australia mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 67. Germany mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 68. France mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 69. UK mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 70. Italy mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 71. Russia mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 72. Spain mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 73. Egypt mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 74. South Africa mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 75. Israel mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 76. Turkey mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries mRNA Vaccines & Therapeutics Market Size 2021-2025 ($ Millions)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets